Bristol-Myers Squibb Co. (BMY) Social Stream
BRISTOL MYERS SQUIBB CO (BMY) Price Targets From Analysts
Use the tables below to see what analysts covering BRISTOL MYERS SQUIBB CO think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-09 | 13 | $80 | $66 | $73.222 | $64.56 | 13.42% |
2021-11-17 | 13 | $80 | $66 | $72.875 | $64.56 | 12.88% |
2021-11-18 | 12 | $80 | $66 | $72.875 | $64.56 | 12.88% |
2021-11-19 | 12 | $80 | $66 | $72.777 | $64.56 | 12.73% |
2022-02-07 | 13 | $80 | $58 | $71.3 | $64.56 | 10.44% |
2022-03-25 | 13 | $80 | $58 | $71.5 | $64.56 | 10.75% |
2022-03-30 | 13 | $81 | $58 | $72.4 | $64.56 | 12.14% |
2022-04-18 | 13 | $81 | $58 | $72.2 | $64.56 | 11.83% |
2022-04-22 | 13 | $85 | $58 | $73.7 | $64.56 | 14.16% |
2022-05-02 | 13 | $85 | $58 | $74.272 | $64.56 | 15.04% |
2022-05-16 | 13 | $92 | $58 | $75.818 | $64.56 | 17.44% |
2022-05-25 | 13 | $92 | $63 | $76.909 | $64.56 | 19.13% |
2022-06-01 | 14 | $92 | $63 | $78 | $64.56 | 20.82% |
2022-06-06 | 14 | $92 | $63 | $78.181 | $64.56 | 21.1% |
2022-07-27 | 15 | $92 | $63 | $78.181 | $64.56 | 21.1% |
2022-07-28 | 17 | $92 | $61 | $79.083 | $64.56 | 22.5% |
2022-08-30 | 17 | $92 | $61 | $78.769 | $64.56 | 22.01% |
2022-09-20 | 17 | $94 | $61 | $79.615 | $64.56 | 23.32% |
2022-10-12 | 18 | $94 | $61 | $79.615 | $64.56 | 23.32% |
2022-10-26 | 18 | $94 | $60 | $79.384 | $64.56 | 22.96% |
2022-10-31 | 18 | $94 | $60 | $79.23 | $64.56 | 22.72% |
2022-12-06 | 16 | $94 | $60 | $79.461 | $64.56 | 23.08% |
2023-01-09 | 17 | $94 | $60 | $80.076 | $64.56 | 24.03% |
2023-01-26 | 18 | $95 | $60 | $81.142 | $64.56 | 25.68% |
2023-02-03 | 18 | $95 | $60 | $81.285 | $64.56 | 25.91% |
2023-02-15 | 18 | $95 | $62 | $81.571 | $64.56 | 26.35% |
2023-04-10 | 19 | $95 | $62 | $80.266 | $64.56 | 24.33% |
2023-04-17 | 19 | $94 | $62 | $79.8 | $64.56 | 23.61% |
2023-04-21 | 19 | $94 | $62 | $79.466 | $64.56 | 23.09% |
2023-04-27 | 19 | $94 | $62 | $79.666 | $64.56 | 23.4% |
2023-04-28 | 19 | $94 | $59 | $79.466 | $64.56 | 23.09% |
2023-05-22 | 19 | $94 | $59 | $79.357 | $64.56 | 22.92% |
The Trend in the Analyst Price Target
Over the past 16 months, BMY's average price target has gone up $8.06.
BMY reports an average of 10.92% for its upside potential over the past 51 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-06-06 | 14 | 92 | 63 | 78.181 | 75.25 | 3.9% |
2022-10-26 | 18 | 94 | 61 | 79.461 | 74.45 | 6.73% |
2023-04-18 | 19 | 94 | 62 | 79.466 | 70.23 | 13.15% |
2023-04-21 | 19 | 94 | 62 | 79.666 | 70.49 | 13.02% |
2023-05-22 | 19 | 94 | 59 | 79.357 | 65.81 | 20.59% |
BMY Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
2.23 | 8 | 0 | 10 | 1 | 1 | 19 |
The Trend in the Broker Recommendations
BMY's average broker recommendation rating worsened by 0.52 over the prior 30 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, BRISTOL MYERS SQUIBB CO's number of analysts covering the stock is higher than 3190.94% of them.
- In the context of Pharmaceutical Products stocks, BRISTOL MYERS SQUIBB CO's upside potential (average analyst target price relative to current price) is greater than 663.14% of them.
- BMY has a greater average analyst price target than 3085.36% of Pharmaceutical Products stocks.
- BRISTOL MYERS SQUIBB CO's variance in analysts' estimates is lower than -777.58% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BRISTOL MYERS SQUIBB CO are LEGN, RPRX, and CVAC.
View All Top Stocks by Price Target
Make investment decisions regarding BMY using the data that counts. Try POWR Ratings for free.